medindia
  1. Medindia
  2. Health Tips and Quotations

Anti-Diabetes Drug Lowers the Risk of Heart Failure

Canagliflozin is an anti-diabetes drug belongs to the gliflozin class or sodium-glucose transport subtype two inhibitors. Canagliflozin is administered either as a monotherapy or with metformin, sulfonylurea drugs, pioglitazone or insulin to achieve adequate glycemic control while treating diabetes patients.

cardiac illness risk assessed in type 2 diabetes patients - canagliflozin lowers the risk of heart failure - confirms a population-based cohort study - canagliflozin compared with other anti-diabetes drugs

Canagliflozin Associated Cardiovascular Outcomes in Type 2 Diabetes

Canagliflozin when compared with other diabetes treating drugs found to lower the risk of heart failure in type 2 diabetes patients who are at high risk for heart disease. Read More

Related Links

Secret Benefits of Rice Water for Skin, Hair, and Health
Orange Peels: A Nutritional Treasure You Have Been Throwing Away
The Rice Diet: From Medical Miracle to Weight Loss Controversy
Benefits of Slow Eating: Enjoy Your Food, Improve Your Health
Top 5 Root Vegetables to Supercharge Your Health
Tamarind: The Tangy Superfruit With Hidden Health Benefits
Don't Lose Sleep Over the End of Daylight Saving: Tips for a Smooth Adjustment
Purple Power: Superfoods to Boost Your Health
Breathe Better: Yoga Techniques to Combat City Pollution
Noise's Luna Ring Revolutionizes Women's Health Tracking With AI-Driven Insights
Loud & Clear: Earphone Side Effects
The Power of Tears: Health Benefits of Crying

Wildcard SSL

Disclaimer - All information and content on this site are for information and educational purposes only. The information should not be used for either diagnosis or treatment or both for any health related problem or disease. Always seek the advice of a qualified physician for medical diagnosis and treatment.
Full Disclaimer

Advertise with us | Medindia Copyright | Privacy Policy | Terms of Use © All Rights Reserved 1997 - 2024